216,444 Shares in Medtronic PLC $MDT Acquired by HRT Financial LP

HRT Financial LP acquired a new stake in shares of Medtronic PLC (NYSE:MDT) in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 216,444 shares of the medical technology company’s stock, valued at approximately $18,867,000.

Other large investors have also made changes to their positions in the company. Brighton Jones LLC raised its holdings in Medtronic by 1,368.0% in the fourth quarter. Brighton Jones LLC now owns 39,989 shares of the medical technology company’s stock valued at $3,194,000 after buying an additional 37,265 shares during the period. Vestmark Advisory Solutions Inc. raised its stake in shares of Medtronic by 98.4% in the 1st quarter. Vestmark Advisory Solutions Inc. now owns 8,746 shares of the medical technology company’s stock valued at $786,000 after acquiring an additional 4,338 shares during the period. Kovitz Investment Group Partners LLC lifted its holdings in shares of Medtronic by 43.8% during the 1st quarter. Kovitz Investment Group Partners LLC now owns 108,030 shares of the medical technology company’s stock valued at $9,708,000 after acquiring an additional 32,907 shares in the last quarter. Horizon Investments LLC increased its holdings in Medtronic by 4.0% in the 1st quarter. Horizon Investments LLC now owns 24,926 shares of the medical technology company’s stock valued at $2,240,000 after purchasing an additional 956 shares in the last quarter. Finally, Aberdeen Group plc lifted its stake in shares of Medtronic by 65.1% during the first quarter. Aberdeen Group plc now owns 2,575,187 shares of the medical technology company’s stock worth $229,282,000 after purchasing an additional 1,015,174 shares in the last quarter. 82.06% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several equities research analysts recently commented on the company. Daiwa Capital Markets raised their target price on Medtronic from $104.00 to $117.00 and gave the company a “buy” rating in a report on Tuesday, November 25th. The Goldman Sachs Group set a $111.00 price objective on shares of Medtronic and gave the company a “neutral” rating in a research report on Wednesday, November 19th. Barclays raised their price target on shares of Medtronic from $109.00 to $111.00 and gave the company an “overweight” rating in a report on Thursday, November 20th. Citigroup upped their price objective on shares of Medtronic from $101.00 to $112.00 and gave the company a “buy” rating in a research report on Tuesday, October 7th. Finally, Piper Sandler reaffirmed a “neutral” rating on shares of Medtronic in a research report on Friday, November 14th. One research analyst has rated the stock with a Strong Buy rating, thirteen have issued a Buy rating and twelve have assigned a Hold rating to the stock. According to MarketBeat.com, Medtronic presently has an average rating of “Moderate Buy” and a consensus price target of $110.44.

Medtronic Trading Up 0.1%

NYSE:MDT opened at $99.86 on Friday. The company has a market cap of $128.02 billion, a PE ratio of 26.92, a P/E/G ratio of 2.63 and a beta of 0.71. The business’s 50 day moving average is $97.27 and its two-hundred day moving average is $92.80. The company has a quick ratio of 1.80, a current ratio of 2.42 and a debt-to-equity ratio of 0.57. Medtronic PLC has a 52 week low of $79.29 and a 52 week high of $106.33.

Medtronic (NYSE:MDT) last announced its quarterly earnings data on Tuesday, November 18th. The medical technology company reported $1.36 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.31 by $0.05. Medtronic had a return on equity of 14.86% and a net margin of 13.71%.The firm had revenue of $8.96 billion for the quarter, compared to analysts’ expectations of $8.86 billion. During the same period last year, the business posted $1.26 earnings per share. The firm’s revenue for the quarter was up 6.6% on a year-over-year basis. Medtronic has set its FY 2026 guidance at 5.620-5.660 EPS. On average, analysts predict that Medtronic PLC will post 5.46 EPS for the current year.

Medtronic Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, January 16th. Stockholders of record on Friday, December 26th will be issued a dividend of $0.71 per share. The ex-dividend date of this dividend is Friday, December 26th. This represents a $2.84 annualized dividend and a dividend yield of 2.8%. Medtronic’s dividend payout ratio is 76.55%.

About Medtronic

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software.